Difference between revisions of "Part:BBa K4156119"

Latest revision as of 01:59, 12 October 2022

XOR gate-HlyE

XOR gate-HlyE consists of an XOR logic gate ( BBa_K4156117 ) and a downstream HlyE ( BBa_K4156084 ) sequence, and tests the performance of the XOR gate by detecting the red fluorescent signal.

Usage and Biology

The construction of this part is similar to XOR gate-mRFP ( BBa_K4156124 ). The difference is that we replaced the mRFP protein with the HlyE therapeutic protein. This is to verify the therapeutic power of the recombinant strain under XOR gate control. After co-incubation of the recombinant strain with cancer cells, cell viability was monitored using the CCK8 assay to assess the therapeutic power of the recombinant strain and the reinforcing effect of the XOR gate.

Characterization

We used three different promoters in combination with XOR gate-HlyE to characterize the therapeutic efficacy of bacteria under the control of different promoters and TP901 coupled logic gates, and with the addition of lysis genes.

Characterization details can be found at：

pCadC-TP901: BBa_K4156099

pCadC-TP901-φ174E: BBa_K4156100

pLldR-TP901: BBa_K4156104

pLldR-TP901-φ174E: BBa_K4156105

pPepT-TP901: BBa_K4156108

pPepT-TP901-φ174E: BBa_K4156109

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
INCOMPATIBLE WITH RFC[21]
Illegal BglII site found at 614
23
COMPATIBLE WITH RFC[23]
25
INCOMPATIBLE WITH RFC[25]
Illegal NgoMIV site found at 104
1000
INCOMPATIBLE WITH RFC[1000]
Illegal BsaI site found at 124
Illegal BsaI.rc site found at 351

@@ Line 3: / Line 3: @@
 <partinfo>BBa_K4156119 short</partinfo>
-To be refined
+XOR gate-HlyE consists of an XOR logic gate (<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156117"> BBa_K4156117 </a></html>) and a downstream HlyE (<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156084"> BBa_K4156084 </a></html>) sequence, and tests the performance of the XOR gate by detecting the red fluorescent signal.
+<!-- Add more about the biology of this part here -->
-<!-- Add more about the biology of this part here
 ===Usage and Biology===
-<!-- -->
+The construction of this part is similar to XOR gate-mRFP (<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156124"> BBa_K4156124 </a></html>). The difference is that we replaced the mRFP protein with the HlyE therapeutic protein. This is to verify the therapeutic power of the recombinant strain under XOR gate control. After co-incubation of the recombinant strain with cancer cells, cell viability was monitored using the CCK8 assay to assess the therapeutic power of the recombinant strain and the reinforcing effect of the XOR gate.
+===Characterization===
+We used three different promoters in combination with XOR gate-HlyE to characterize the therapeutic efficacy of bacteria under the control of different promoters and TP901 coupled logic gates, and with the addition of lysis genes.
+Characterization details can be found at：
+pCadC-TP901:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156099"> BBa_K4156099 </a></html>
+pCadC-TP901-φ174E:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156100"> BBa_K4156100 </a></html>
+pLldR-TP901:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156104"> BBa_K4156104 </a></html>
+pLldR-TP901-φ174E:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156105"> BBa_K4156105 </a></html>
+pPepT-TP901:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156108"> BBa_K4156108 </a></html>
+pPepT-TP901-φ174E:<html><a style="padding: 0px; margin: 0px;" href="https://parts.igem.org/Part:BBa_K4156109"> BBa_K4156109 </a></html>
 <span class='h3bb'>Sequence and Features</span>
 <partinfo>BBa_K4156119 SequenceAndFeatures</partinfo>